Page last updated: 2024-09-02

fingolimod hydrochloride and Sarcoma, Alveolar Soft Part

fingolimod hydrochloride has been researched along with Sarcoma, Alveolar Soft Part in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawai, A; Kondo, T; Kubota, D; Yoshida, A1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Sarcoma, Alveolar Soft Part

ArticleYear
Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma.
    Journal of proteome research, 2014, May-02, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Electrophoresis, Gel, Two-Dimensional; Enzyme Activators; Female; Fingolimod Hydrochloride; Histone Chaperones; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; Propylene Glycols; Protein Phosphatase 2; Proteome; Proteomics; RNA Interference; Sarcoma, Alveolar Soft Part; Sphingosine; Transcription Factors; Young Adult

2014